Kythera Biopharmaceuticals, Inc.: Series C $10M

Posted in I - Series C, Q - 1Q09, R - WEST, X - Aesthetics, X - Dermatology, XX - CA

Kythera Biopharmaceuticals (Calabasas, CA) a clinical-stage biopharmaceutical company focused on aesthetic dermatology, closed a $10M Sereis C financing, bringing the total round to $40M. Participants include Versant Ventures, ARCH Venture Partners, Prospect Venture Partners, BBT Capital Management, JAFCO Ventures and Altitude Life Science Ventures.

Garnet Biotherapeutics, Inc.: Series A $10.4M

Posted in I - Series A, Q - 1Q09, R - NORTH EAST, X - Dermatology, XX - PA

Garnet Biotherapeutics (Malvern, PA) a regenerative medicine company focused on dermatology, closed a $10.4M Series A financing. Participants include SCP Vitalife Partners, Safeguard Scientifics and Alliance Technology Ventures.

Sol-Gel Technologies, Ltd.: Series B $9M

Posted in I - Series B, Q - 4Q08, R - INTERNATIONAL, X - Dermatology

Sol-Gel Technologies (Israel) developer of microencapsulation technology topical products for the dermatology applications, closed a $9M Series B financing. Participants include Medica Venture Partners, JVP and DSM Corporate Venturing.

Serentics, Inc.: Series A $8.2M

Posted in I - Series A, Q - 3Q08, R - INTERNATIONAL, X - Dermatology

Serentis (United Kingdom) early-stage dermatology company, closed a $8.2M Series A financing. Participants include MVM Life Science Partners, Apposite Capital, East Hill and Novo.

Collegium Pharmaceutical, Inc.: Series D $20M

Posted in I - Series D, Q - 3Q08, R - NORTH EAST, X - CNS, X - Dermatology, X - Respiratory

Collegium Pharmaceutical (Cumberland, RI) commercial-stage specialty pharmaceutical company focused on late-stage development therapeutics for central nervous system, respiratory and skin related disorders, closed a $20M Series D financing. Participants include Frazier Healthcare Ventures.

Creabilis Therapeutics, SpA: Series A $25M

Posted in I - Series A, Q - 2Q08, R - INTERNATIONAL, X - Dermatology

Creabilis Therapeutics (Italy) dermatological drug start-up focused on psoriasis, dermatitis, and Behcet’s Disease, closed a $25M Series A financing. Participants include Sofinnova Partners and NeoMed Management.

Myoscience, Inc.: Series B $8.4M

Posted in I - Series B, Q - 2Q08, R - WEST, X - Aesthetics, X - Dermatology

Myoscience (Redwood City, CA) early-stage biotech focused on dermatology and aesthetic medicine closed a $8.4M Series B financing. Participants include Accuitive Medical Ventures, De Novo Ventures and Saratoga Ventures.

Quinnova Pharmaceuticals: Series A $13.6M

Posted in I - Series A, R - NORTH EAST, X - Dermatology

Quinnova Pharmaceuticals, Inc., a specialty dermatological reformulation pharmaceutical company focused on innovative dermal drug delivery platforms, has completed a $13.6M Series A round of financing. Participating in the round are Thomas, McNerney & Partners, H.I.G. Ventures and an investor syndicate led by Omnivest (Bermuda) Ltd.

Next Entries »

to top of page...